on Affluent Medical (isin : FR0013333077)
Affluent Medical establishes new liquidity contract
On December 18, 2024, Affluent Medical, a French implantable medical device company, announced the implementation of a new liquidity contract. This change comes after the end of the previous contract with Kepler Cheuvreux, which was terminated on December 17, 2024.
As of December 18, 2024, Rothschild Martin Maurel is responsible for the animation of Affluent Medical shares on Euronext Paris. This contract, for a renewable period of one year, aims to enrich liquidity and ensure the regularity of the share listing.
The resources allocated to the new liquidity contract include 144,305 securities and a balance of 19,705.22 euros, identical to those of the previous contract. Suspensions may be carried out in accordance with AMF regulations or for technical needs.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Affluent Medical news